PHASE II STUDY OF CARBOPLATIN-DOCETAXEL-BEVACIZUMAB AS FRONT-LINE TREATMENT IN PATIENTS WITH STAGE IV NON-SQUAMOUS NON-SMALL-CELL LUNG CANCER. ANALYSIS OF THE BEVACIZUMAB (BVZ) MAINTENANCE POPULATION
JOURNAL OF THORACIC ONCOLOGY(2013)
Key words
metastatic,Bevacizumab,Maintenance treatment,Non squamous NSCLC
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined